Home > > > > > Report Detail

Global Parkinson's Disease (PD) Drugs Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Publisher Name :
Date: 20-Dec-2019
No. of pages: 131
Inquire Before Buying

Summary

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.

The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain traction in the market for parkinsons drugs throughout the estimated period.

The global Parkinson's Disease (PD) Drugs market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.

This report studies the Parkinson's Disease (PD) Drugs market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Parkinson's Disease (PD) Drugs in these regions, from 2014 to 2025, covering

- North America (United States, Canada and Mexico)

- Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

- South America (Brazil etc.)

- Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

- Boehringer Ingelheim

- GlaxoSmithKline

- Novartis

- Teva Pharmaceutical Industries

- AbbVie

- Abital Pharma

- Addex Therapeutics

- Biogen

- Eisai

- Eli Lilly

- F. Hoffmann-La Roche

- H. Lundbeck

- Impax Laboratories

- Kyowa Hakko Kirin

- Otsuka Pharmaceutical

- Pfizer

By the product type, the market is primarily split into

- Dopamine Agonist

- Monoamine Oxidase Inhibitors

- Acetylcholinesterase Inhibitors

- Glutamate Inhibitors

By the end users/application, this report covers the following segments

- Hospital

- Family

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Central & South America

- - Brazil

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Parkinson's Disease (PD) Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Parkinson's Disease (PD) Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Parkinson's Disease (PD) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Parkinson's Disease (PD) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Parkinson's Disease (PD) Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Parkinson's Disease (PD) Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parkinson's Disease (PD) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Parkinson's Disease (PD) Drugs market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Global Parkinson's Disease (PD) Drugs Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Table of Contents
1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Parkinson's Disease (PD) Drugs Product Overview
1.2 Parkinson's Disease (PD) Drugs Market Segment by Type
1.2.1 Dopamine Agonist
1.2.2 Monoamine Oxidase Inhibitors
1.2.3 Acetylcholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Global Parkinson's Disease (PD) Drugs Market Size by Type
1.3.1 Global Parkinson's Disease (PD) Drugs Sales and Growth by Type
1.3.2 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Type
1.3.3 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Type
1.3.4 Global Parkinson's Disease (PD) Drugs Price by Type
1.4 North America Parkinson's Disease (PD) Drugs by Type
1.5 Europe Parkinson's Disease (PD) Drugs by Type
1.6 South America Parkinson's Disease (PD) Drugs by Type
1.7 Middle East and Africa Parkinson's Disease (PD) Drugs by Type
2 Global Parkinson's Disease (PD) Drugs Market Competition by Company
2.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Company (2014-2019)
2.2 Global Parkinson's Disease (PD) Drugs Revenue and Share by Company (2014-2019)
2.3 Global Parkinson's Disease (PD) Drugs Price by Company (2014-2019)
2.4 Global Top Players Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
2.5.2 Global Parkinson's Disease (PD) Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Parkinson's Disease (PD) Drugs Company Profiles and Sales Data
3.1 Boehringer Ingelheim
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 GlaxoSmithKline
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Novartis
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Teva Pharmaceutical Industries
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 AbbVie
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Abital Pharma
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Addex Therapeutics
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Biogen
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Eisai
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Eli Lilly
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Parkinson's Disease (PD) Drugs Product Category, Application and Specification
3.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 F. Hoffmann-La Roche
3.12 H. Lundbeck
3.13 Impax Laboratories
3.14 Kyowa Hakko Kirin
3.15 Otsuka Pharmaceutical
3.16 Pfizer
4 Parkinson's Disease (PD) Drugs Market Status and Outlook by Regions
4.1 Global Parkinson's Disease (PD) Drugs Market Status and Outlook by Regions
4.1.1 Global Parkinson's Disease (PD) Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Parkinson's Disease (PD) Drugs Sales and Revenue by Regions
4.2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2014-2019)
4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions (2014-2019)
4.2.3 Global Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin
4.3.1 North America Parkinson's Disease (PD) Drugs Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin
4.6.1 South America Parkinson's Disease (PD) Drugs Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa
5 Parkinson's Disease (PD) Drugs Application
5.1 Parkinson's Disease (PD) Drugs Segment by Application
5.1.1 Hospital
5.1.2 Family
5.2 Global Parkinson's Disease (PD) Drugs Product Segment by Application
5.2.1 Global Parkinson's Disease (PD) Drugs Sales by Application
5.2.2 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Application (2014-2019)
5.3 North America Parkinson's Disease (PD) Drugs by Application
5.4 Europe Parkinson's Disease (PD) Drugs by Application
5.5 Asia-Pacific Parkinson's Disease (PD) Drugs by Application
5.6 South America Parkinson's Disease (PD) Drugs by Application
5.7 Middle East and Africa Parkinson's Disease (PD) Drugs by Application
6 Global Parkinson's Disease (PD) Drugs Market Forecast
6.1 Global Parkinson's Disease (PD) Drugs Sales, Revenue Forecast (2019-2025)
6.1.1 Global Parkinson's Disease (PD) Drugs Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Parkinson's Disease (PD) Drugs Forecast by Regions
6.2.1 North America Parkinson's Disease (PD) Drugs Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Parkinson's Disease (PD) Drugs Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Revenue Forecast (2019-2025)
6.2.4 South America Parkinson's Disease (PD) Drugs Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Revenue Forecast (2019-2025)
6.3 Parkinson's Disease (PD) Drugs Forecast by Type
6.3.1 Global Parkinson's Disease (PD) Drugs Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Dopamine Agonist Growth Forecast
6.3.3 Monoamine Oxidase Inhibitors Growth Forecast
6.4 Parkinson's Disease (PD) Drugs Forecast by Application
6.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2019-2025)
6.4.2 Global Parkinson's Disease (PD) Drugs Forecast in Hospital
6.4.3 Global Parkinson's Disease (PD) Drugs Forecast in Family
7 Parkinson's Disease (PD) Drugs Upstream Raw Materials
7.1 Parkinson's Disease (PD) Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables and Figures
Figure Parkinson's Disease (PD) Drugs Product Picture
Figure Global Parkinson's Disease (PD) Drugs Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Status and Outlook (2014-2025)
Figure Product Picture of Dopamine Agonist
Table Major Players of Dopamine Agonist
Figure Global Dopamine Agonist Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Monoamine Oxidase Inhibitors
Table Major Players of Monoamine Oxidase Inhibitors
Figure Global Monoamine Oxidase Inhibitors Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Acetylcholinesterase Inhibitors
Table Major Players of Acetylcholinesterase Inhibitors
Figure Global Acetylcholinesterase Inhibitors Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Glutamate Inhibitors
Table Major Players of Glutamate Inhibitors
Figure Global Glutamate Inhibitors Sales (K Pcs) and Growth Rate (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Comparison by Type (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Global Parkinson's Disease (PD) Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type in 2018
Table Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2014-2019)
Table North America Parkinson's Disease (PD) Drugs Sales (USD/Pcs) by Type (2014-2019)
Figure North America Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Europe Parkinson's Disease (PD) Drugs Sales (USD/Pcs) by Type (2014-2019)
Figure Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Asia-Pacific Parkinson's Disease (PD) Drugs Sales (USD/Pcs) by Type (2014-2019)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table South America Parkinson's Disease (PD) Drugs Sales (USD/Pcs) by Type (2014-2019)
Figure South America Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales (USD/Pcs) by Type (2014-2019)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Company (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Share by Company in 2018
Table Global Parkinson's Disease (PD) Drugs Revenue (Million US$) by Company (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Revenue Share by Company (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Share by Company in 2018
Table Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) by Company (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Top Company Manufacturing Base Distribution and Sales Area
Table Global Parkinson's Disease (PD) Drugs Top Manufacturers Product Category
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Figure Global Parkinson's Disease (PD) Drugs Market Share of Top 5 Company
Figure Global Parkinson's Disease (PD) Drugs Market Share of Top 10 Company
Table Mergers & Acquisitions, Expansion Plans
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Boehringer Ingelheim Description and Business Overview
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Description and Business Overview
Table Novartis Basic Information List
Table Novartis Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Novartis Description and Business Overview
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Teva Pharmaceutical Industries Description and Business Overview
Table AbbVie Basic Information List
Table AbbVie Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure AbbVie Description and Business Overview
Table Abital Pharma Basic Information List
Table Abital Pharma Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Abital Pharma Description and Business Overview
Table Addex Therapeutics Basic Information List
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Addex Therapeutics Description and Business Overview
Table Biogen Basic Information List
Table Biogen Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Biogen Description and Business Overview
Table Eisai Basic Information List
Table Eisai Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Eisai Description and Business Overview
Table Eli Lilly Basic Information List
Table Eli Lilly Parkinson's Disease (PD) Drugs Product Category, Application and Specification
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Eli Lilly Description and Business Overview
Table F. Hoffmann-La Roche Basic Information List
Table H. Lundbeck Basic Information List
Table Impax Laboratories Basic Information List
Table Kyowa Hakko Kirin Basic Information List
Table Otsuka Pharmaceutical Basic Information List
Table Pfizer Basic Information List
Table Global Parkinson's Disease (PD) Drugs Market Size Comparison by Regions (2014-2025) (K Pcs) & (Million US$)
Figure North America Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure South America Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Regions (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2014-2019)
Figure 2018 Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions
Table Global Parkinson's Disease (PD) Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions (2014-2019)
Figure 2018 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure North America Parkinson's Disease (PD) Drugs Sales Growth Rate
Table North America Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Canada Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Canada Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Mexico Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Mexico Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Europe Parkinson's Disease (PD) Drugs Sales Growth Rate
Table Europe Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Germany Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Germany Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure France Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure France Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure UK Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure UK Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Italy Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Italy Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Russia Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Russia Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Sales Growth Rate
Table Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure China Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure China Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Japan Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Japan Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure South Korea Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure South Korea Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure India Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure India Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Australia Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Australia Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Indonesia Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Indonesia Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Thailand Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Thailand Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Malaysia Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Malaysia Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Philippines Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Philippines Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Vietnam Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Vietnam Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure South America Parkinson's Disease (PD) Drugs Sales Growth Rate
Table South America Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Brazil Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Brazil Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales Growth Rate
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Turkey Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Turkey Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure GCC Countries Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure GCC Countries Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Egypt Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure Egypt Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure South Africa Parkinson's Disease (PD) Drugs Sales (K Pcs)(2014-2019)
Figure South Africa Parkinson's Disease (PD) Drugs Revenue (Million USD)(2014-2019)
Figure Hospital Examples
Figure Family Examples
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Comparison by Application (2014-2025)
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2014-2019)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Application (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2018
Figure Global Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Regions (2019-2025)
Figure North America Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure North America Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Europe Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure China Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Japan Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South Korea Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South Korea Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure India Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Australia Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Australia Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Indonesia Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Indonesia Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South America Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South America Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Turkey Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Turkey Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure GCC Countries Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure GCC Countries Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Egypt Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Egypt Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South Africa Parkinson's Disease (PD) Drugs Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South Africa Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
Table Global Parkinson's Disease (PD) Drugs Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2019-2025)
Table Global Parkinson's Disease (PD) Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2019-2025)
Figure Dopamine Agonist Sales Growth Forecast
Figure Monoamine Oxidase Inhibitors Sales Growth Forecast
Table Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2019-2025)
Figure Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast in Hospital
Figure Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast in Family
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Parkinson's Disease (PD) Drugs Manufacturing Cost Structure
Figure Parkinson's Disease (PD) Drugs Industrial Chain Analysis
Table Distributors List
Table Parkinson's Disease (PD) Drugs Downstream Customers
Table Research Programs/Design for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs